Elucidating the specific pharmacological system of motion (MOA) of Normally developing compounds is often complicated. While Tarselli et al. (sixty) formulated the 1st de novo

At the moment, conolidine can be an investigational compound and isn't offered being a medication. It hasn't been authorized to be used by regulatory bodies like the U.